GenRx Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Dostupno od:

Arrotex Pharmaceuticals Pty Ltd

INN (International ime):

pemetrexed disodium hemipentahydrate

Farmaceutski oblik:

Injection, powder for

Sastav:

Excipient Ingredients: mannitol; hydrochloric acid; sodium hydroxide

Administracija rute:

Intravenous Infusion

Jedinice u paketu:

1

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Proizvod sažetak:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autorizacije:

Licence status A

Datum autorizacije:

2014-09-04